跳至主要内容
临床试验/CTRI/2025/07/091034
CTRI/2025/07/091034尚未招募不适用

A study of Heart rate Variability for Prediction of Response to Selective Serotonin Reuptake Inhibitor (SSRI) & Selective partial Agonist and Reuptake Inhibitor (SPARI) in Generalised Anxiety Disorder

Daniyal Farooque1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年8月10日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Heart Rate Variability

研究概览

简要总结

This is a prospective observational study aimed at evaluating the role of heart rate variability in predicting response to Selective Serotonin Reuptake Inhibitors and Selective Partial Agonist and Reuptake Inhibitors in patients with Generalized Anxiety Disorder. Patients will be assigned to two treatment groups based on the prescribed medication and compared with a healthy control group. Heart rate variability and anxiety severity will be assessed before and after eight weeks of treatment. The study aims to identify whether heart rate variability can serve as a predictive marker to guide personalized treatment decisions in anxiety disorders

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Adult patients of generalized anxiety disorder with moderate or severe anxiety based on Hamilton anxiety rating scale (HAM-A).

排除标准

  • Any physical or psychiatric co-morbidity except insomnia Patient with heart disease or taking any heart rate controlling drugs like beta blockers.
  • Pregnancy Patient with pacemaker implant.
  • Severe systemic disease, cardiopulmonary or kidney insufficiency.

结局指标

主要结局

Heart Rate Variability

时间窗: 1. Baseline | 2. After 8 weeks of treatment

次要结局

未报告次要终点

研究者

发起方
Daniyal Farooque
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Daniyal Farooque

Jawaharlal Nehru Medical College, Aligarh

研究点 (1)

Loading locations...

相似试验

Study to Find Out if Heartbeat Changes Can Help... | 临床试验